PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma
Ajay K. Gopal, Brad S. Kahl, Svende Vos, Nina D. Wagner-Johnston, Stephen J. Schuster, Wojciech J. Jurczak, Ian W. Flinn, Christopher R. Flowers, Peter Martin, Andreas Viardot, Kristie A. Blum, Andre H. Goy, Andrew J. Davies, Pier Luigi Zinzani, Martin Dreyling, Dave Johnson, Langdon L. Miller, Leanne Holes, Daniel Li, Roger D. DanseyWayne R. Godfrey, Gilles A. Salles
Dive into the research topics of 'PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma'. Together they form a unique fingerprint.